Published in Chest on January 01, 2006
Management of asthma in adults. CMAJ (2009) 1.43
Asthma exacerbations . 4: Prevention. Thorax (2006) 1.17
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med (2009) 5.90
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet (2003) 5.10
Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 4.41
The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med (2008) 3.01
Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med (2014) 2.53
A GABAergic system in airway epithelium is essential for mucus overproduction in asthma. Nat Med (2007) 2.43
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med (2010) 2.31
Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med (2003) 1.94
Risks of long-acting beta-agonists in achieving asthma control. N Engl J Med (2009) 1.89
Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol (2009) 1.76
Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med (2004) 1.71
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol (2008) 1.59
Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma. J Allergy Clin Immunol (2010) 1.58
Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction. J Allergy Clin Immunol (2002) 1.56
Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial. Pediatr Allergy Immunol (2006) 1.54
Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol (2002) 1.49
Asthma management by monitoring sputum neutrophil count. Chest (2008) 1.44
Increased levels of airway neutrophils reduce the inhibitory effects of inhaled glucocorticosteroids on allergen-induced airway eosinophils. Can Respir J (2002) 1.43
Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol (2010) 1.41
Omalizumab and the immune system: an overview of preclinical and clinical data. Ann Allergy Asthma Immunol (2002) 1.41
Clinical models to compare the safety and efficacy of inhaled corticosteroids in patients with asthma. Can Respir J (2003) 1.40
Recent advances in the pathophysiology of asthma. Chest (2010) 1.30
Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med (2003) 1.25
Effect of interferon-gamma on allergic airway responses in interferon-gamma-deficient mice. Am J Respir Crit Care Med (2002) 1.24
Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. Am J Respir Crit Care Med (2003) 1.24
The demise of anti IL-5 for asthma, or not. Am J Respir Crit Care Med (2007) 1.24
Sputum CD34+IL-5Ralpha+ cells increase after allergen: evidence for in situ eosinophilopoiesis. Am J Respir Crit Care Med (2003) 1.21
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone. Thorax (2013) 1.08
Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology (2003) 1.06
A role for sensory nerves in the late asthmatic response. Thorax (2011) 1.06
Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med (2008) 1.05
Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am J Respir Crit Care Med (2006) 1.02
Reassessing the Th2 cytokine basis of asthma. Trends Pharmacol Sci (2004) 0.99
Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J Allergy Clin Immunol (2004) 0.98
The effect of omalizumab on nasal allergic inflammation. J Allergy Clin Immunol (2002) 0.97
The effects of intranasal budesonide on allergen-induced production of interleukin-5 and eotaxin, airways, blood, and bone marrow eosinophilia, and eosinophil progenitor expansion in sensitized mice. Am J Respir Crit Care Med (2002) 0.95
Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. Am J Respir Crit Care Med (2002) 0.94
Ozone enhances the airway inflammation initiated by diesel exhaust. Respir Med (2006) 0.93
Predictors of loss of asthma control induced by corticosteroid withdrawal. Can Respir J (2006) 0.93
Progenitor egress from the bone marrow after allergen challenge: role of stromal cell-derived factor 1alpha and eotaxin. J Allergy Clin Immunol (2005) 0.93
Understanding allergic asthma from allergen inhalation tests. Can Respir J (2007) 0.93
Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. J Allergy Clin Immunol (2010) 0.92
Lung homing of endothelial progenitor cells in humans with asthma after allergen challenge. Am J Respir Crit Care Med (2011) 0.92
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res (2011) 0.91
Cysteinyl leukotrienes promote human airway smooth muscle migration. Am J Respir Crit Care Med (2002) 0.91
Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma. J Allergy Clin Immunol (2005) 0.91
Inhaled allergen bronchoprovocation tests. J Allergy Clin Immunol (2013) 0.91
Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma. Am J Respir Crit Care Med (2002) 0.91
The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. J Allergy Clin Immunol (2006) 0.90
Anti-allergic therapies: effects on eosinophil progenitors. Pharmacol Ther (2002) 0.90
IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma. Int Arch Allergy Immunol (2013) 0.90
In vivo-to-in silico iterations to investigate aeroallergen-host interactions. PLoS One (2008) 0.89
Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. Chest (2007) 0.89
Different profiles of T-cell IFN-gamma and IL-12 in allergen-induced early and dual responders with asthma. J Allergy Clin Immunol (2005) 0.89
Asthma and exercise-induced bronchoconstriction in athletes. N Engl J Med (2015) 0.88
Morphometric analysis of mouse airways after chronic allergen challenge. Lab Invest (2003) 0.88
Decreased miR-192 expression in peripheral blood of asthmatic individuals undergoing an allergen inhalation challenge. BMC Genomics (2012) 0.87
Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects. Respir Res (2011) 0.87
Levalbuterol has not been established to have therapeutic advantage over racemic albuterol. J Allergy Clin Immunol (2002) 0.87
Acute, but not resolved, influenza A infection enhances susceptibility to house dust mite-induced allergic disease. J Immunol (2009) 0.87
Airway hyperresponsiveness and calcium handling by smooth muscle: a "deeper look". Chest (2002) 0.86
Inhaled corticosteroids for asthma: common clinical quandaries. J Asthma (2003) 0.86
Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. Chest (2006) 0.85
Diesel exhaust but not ozone increases fraction of exhaled nitric oxide in a randomized controlled experimental exposure study of healthy human subjects. Environ Health (2013) 0.85
Peripheral blood gene expression changes during allergen inhalation challenge in atopic asthmatic individuals. J Asthma (2012) 0.85
IL-10 production in circulating T cells differs between allergen-induced isolated early and dual asthmatic responders. J Allergy Clin Immunol (2002) 0.84
Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. J Allergy Clin Immunol (2006) 0.84
Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Pro. Am J Respir Crit Care Med (2005) 0.84
The effect of omega-3 fatty acids on bronchial hyperresponsiveness, sputum eosinophilia, and mast cell mediators in asthma. Chest (2015) 0.84
The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta-analysis. Pol Arch Med Wewn (2008) 0.84
Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control. Chest (2010) 0.82
Exhaled nitric oxide in guideline-based asthma management. Lancet (2008) 0.81
Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy. J Allergy Clin Immunol (2005) 0.81
The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma. Am J Respir Crit Care Med (2004) 0.81
An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma. Respir Med (2004) 0.81
Shifting of immune responsiveness to house dust mite by influenza A infection: genomic insights. J Immunol (2011) 0.80
Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics. Respirology (2008) 0.80
Gene-metabolite expression in blood can discriminate allergen-induced isolated early from dual asthmatic responses. PLoS One (2013) 0.80
The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction. J Allergy Clin Immunol (2012) 0.79
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids. J Negat Results Biomed (2014) 0.79
Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challenge. Proteomics Clin Appl (2012) 0.79
Combination inhaled corticosteroid and long-acting β2-agonist use and severe asthma exacerbations. J Allergy Clin Immunol (2012) 0.79
Decreased CTLA4(+) and Foxp3(+) CD25(high)CD4(+) cells in induced sputum from patients with mild atopic asthma. Allergol Int (2013) 0.79
Modulation of beta1-integrins on hemopoietic progenitor cells after allergen challenge in asthmatic subjects. J Allergy Clin Immunol (2008) 0.78
Effectiveness of early budesonide intervention in Caucasian versus Asian patients with asthma: 3-year results of the START study. Respirology (2006) 0.78
Pulmonary function testing in the emergency department and medications prescribed at discharge: results of the Multinational Acute asthma Management, Burden, and Outcomes (MAMBO) study. Prim Care Respir J (2010) 0.78
Increased serum levels of soluble IL-18 receptor complex in patients with allergic asthma. Allergol Int (2013) 0.77
T helper 17 cells and related cytokines after allergen inhalation challenge in allergic asthmatics. Int Arch Allergy Immunol (2014) 0.76
A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses. Am J Respir Crit Care Med (2015) 0.76
The pharmacological modulation of allergen-induced asthma. Inflammopharmacology (2012) 0.76
Asthma in the real world. J Allergy Clin Immunol (2013) 0.76
Allergen-Induced Increases in Interleukin-25 and Interleukin-25 Receptor Expression in Mature Eosinophils from Atopic Asthmatics. Int Arch Allergy Immunol (2016) 0.75
Asthma Management Guidelines: the issue of implementation. Prim Care Respir J (2006) 0.75
Effects of ASM-024, a modulator of acetylcholine receptor function, on airway responsiveness and allergen-induced responses in patients with mild asthma. Can Respir J (2015) 0.75
The airway epithelium in childhood asthma. J Allergy Clin Immunol (2012) 0.75
[Evidence-based medicine--a new course in medical education]. Lakartidningen (2002) 0.75